236 related articles for article (PubMed ID: 10524448)
1. Adjuvant chemotherapy with vincristine, doxorubicin, and cyclophosphamide in the treatment of postenucleation high risk retinoblastoma.
Mustafa MM; Jamshed A; Khafaga Y; Mourad WA; Al-Mesfer S; Kofide A; El-Husseiny G; Gray A
J Pediatr Hematol Oncol; 1999; 21(5):364-9. PubMed ID: 10524448
[TBL] [Abstract][Full Text] [Related]
2. Results of a stage-based protocol for the treatment of retinoblastoma.
Schvartzman E; Chantada G; Fandiño A; de Dávila MT; Raslawski E; Manzitti J
J Clin Oncol; 1996 May; 14(5):1532-6. PubMed ID: 8622068
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Nonmetastatic Unilateral Retinoblastoma in Children.
Pérez V; Sampor C; Rey G; Parareda-Salles A; Kopp K; Dabezies AP; Dufort G; Zelter M; López JP; Urbieta M; Alcalde-Ruiz E; Catala-Mora J; Suñol M; Ossandon D; Fandiño AC; Croxatto JO; de Dávila MTG; Reaman G; Ravindranath Y; Chantada GL
JAMA Ophthalmol; 2018 Jul; 136(7):747-752. PubMed ID: 29799944
[TBL] [Abstract][Full Text] [Related]
4. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.
Kaliki S; Shields CL; Shah SU; Eagle RC; Shields JA; Leahey A
Arch Ophthalmol; 2011 Nov; 129(11):1422-7. PubMed ID: 22084213
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination.
Uusitalo MS; Van Quill KR; Scott IU; Matthay KK; Murray TG; O'Brien JM
Arch Ophthalmol; 2001 Jan; 119(1):41-8. PubMed ID: 11146725
[TBL] [Abstract][Full Text] [Related]
6. Microscopic scleral invasion in retinoblastoma: clinicopathological features and outcome.
Cuenca A; Giron F; Castro D; Fandiño A; Guitter M; de Dávila MT; Chantada G
Arch Ophthalmol; 2009 Aug; 127(8):1006-10. PubMed ID: 19667337
[TBL] [Abstract][Full Text] [Related]
7. Results of a prospective study for the treatment of retinoblastoma.
Chantada G; Fandiño A; Dávila MT; Manzitti J; Raslawski E; Casak S; Schvartzman E
Cancer; 2004 Feb; 100(4):834-42. PubMed ID: 14770442
[TBL] [Abstract][Full Text] [Related]
8. Postenucleation adjuvant therapy in high-risk retinoblastoma.
Honavar SG; Singh AD; Shields CL; Meadows AT; Demirci H; Cater J; Shields JA
Arch Ophthalmol; 2002 Jul; 120(7):923-31. PubMed ID: 12096963
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre.
Künkele A; Wilm J; Holdt M; Lohmann D; Bornfeld N; Eggert A; Temming P; Schulte JH
Br J Ophthalmol; 2015 Jul; 99(7):949-53. PubMed ID: 25583279
[TBL] [Abstract][Full Text] [Related]
10. Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation.
Aerts I; Sastre-Garau X; Savignoni A; Lumbroso-Le Rouic L; Thebaud-Leculée E; Frappaz D; Coze C; Thomas C; Gauthier-Villars M; Lévy-Gabriel C; Brisse HJ; Desjardins L; Doz F
J Clin Oncol; 2013 Apr; 31(11):1458-63. PubMed ID: 23460706
[TBL] [Abstract][Full Text] [Related]
11. Retinoblastoma in children older than 5 years of age.
de Aguirre Neto JC; Antoneli CB; Ribeiro KB; Castilho MS; Novaes PE; Chojniak MM; Arias V
Pediatr Blood Cancer; 2007 Mar; 48(3):292-5. PubMed ID: 16847922
[TBL] [Abstract][Full Text] [Related]
12. Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.
Chévez-Barrios P; Eagle RC; Krailo M; Piao J; Albert DM; Gao Y; Vemuganti G; Ali MJ; Khetan V; Honavar SG; O'Brien J; Leahey AM; Matthay K; Meadows A; Chintagumpala M
J Clin Oncol; 2019 Nov; 37(31):2883-2891. PubMed ID: 31539297
[TBL] [Abstract][Full Text] [Related]
13. The Potential Benefit of Three vs. Six Cycles of Carboplatin, Etoposide, and Vincristine in Postenucleation High-Risk Patients with IRSS Stage I Retinoblastoma.
Ye H; Du Y; Chen R; Luo X; Mao Y; Ai S; Ma W; Ding Y; Li Q; Yang H
Curr Eye Res; 2016 Nov; 41(11):1507-1512. PubMed ID: 27158739
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic observation of 465 patients with retinoblastoma with optic nerve invasion].
Wang Y; Huang D; Shi J; Ma J; Zhao J; Li B; Xu X; Hu H; Zhou Y
Zhonghua Er Ke Za Zhi; 2015 Feb; 53(2):109-13. PubMed ID: 25876685
[TBL] [Abstract][Full Text] [Related]
15. Multimodal Therapy for Stage III Retinoblastoma (International Retinoblastoma Staging System): A Prospective Comparative Study.
Chawla B; Hasan F; Seth R; Pathy S; Pattebahadur R; Sharma S; Upadhyaya A; Azad R
Ophthalmology; 2016 Sep; 123(9):1933-9. PubMed ID: 27449712
[TBL] [Abstract][Full Text] [Related]
16. Delayed Enucleation With Neoadjuvant Chemotherapy in Advanced Intraocular Unilateral Retinoblastoma: AHOPCA II, a Prospective, Multi-Institutional Protocol in Central America.
Luna-Fineman S; Chantada G; Alejos A; Amador G; Barnoya M; Castellanos ME; Fu L; Fuentes-Alabi S; Girón V; Goenz MA; Maldonado C; Méndez G; Morales RA; Ortiz R; Sanchez G; Wilson M; Rodríguez-Galindo C
J Clin Oncol; 2019 Nov; 37(31):2875-2882. PubMed ID: 31536438
[TBL] [Abstract][Full Text] [Related]
17. Preliminary results of primary chemotherapy in retinoblastoma.
Bornfeld N; Schüler A; Bechrakis N; Henze G; Havers W
Klin Padiatr; 1997; 209(4):216-21. PubMed ID: 9293453
[TBL] [Abstract][Full Text] [Related]
18. Extraocular retinoblastoma: a 13-year experience.
Antoneli CB; Steinhorst F; de Cássia Braga Ribeiro K; Novaes PE; Chojniak MM; Arias V; de Camargo B
Cancer; 2003 Sep; 98(6):1292-8. PubMed ID: 12973854
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
Chantada GL; Dunkel IJ; Antoneli CB; de Dávila MT; Arias V; Beaverson K; Fandiño AC; Chojniak M; Abramson DH
Pediatr Blood Cancer; 2007 Sep; 49(3):256-60. PubMed ID: 17029248
[TBL] [Abstract][Full Text] [Related]
20. The treatment of retinoblastoma with four-drug regimen including cisplatin, etoposide, vincristine, and cyclophosphamide.
Varan A; Kiratli H; Aydın B; Tarlan B; Poyraz CB; Akyüz C; Büyükpamukçu M
Pediatr Hematol Oncol; 2012 Sep; 29(6):529-37. PubMed ID: 22759219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
